Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape

B NANJING, China, May 11, 2026 /PRNewswire/ — Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs”; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai.…
posteditor
posteditor
Articles: 21727

Other News